Paradigm Diagnostics Competitors and Similar CompaniesClear all
Arch Oncology's competitors and similar companies include Divide & Conquer.
 Arch Oncology Arch Oncology is a clinical-stage immuno-oncology company focused on the discovery and development of antibody therapies for the treatment of patients with cancer. |  Divide & Conquer Divide & Conquer is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumors with very poor life expectancy. | |
Founding Date | Founding Date 2006 | Founding Date 2018 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Brisbane, US HQ St. Louis, US | Locations Babraham, GB HQ |
Employees | Employees 7 | Employees 2 |
Funding | ||
Latest funding round | Latest funding round $ 105m (about 5 years ago) | Latest funding round $ 12.5m (over 6 years ago) |
Total funding raised | Total funding raised $ 155m | Total funding raised $ 12.5m |
For sources of this data, please see the company profile
View Company Profiles
Divide & Conquer
HQ
Babraham, GB
Employees
2
Divide & Conquer is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumors with very poor life expectancy.
View company